arrow
S

Sylvia Villeneuve

mcgill university
H指数:45
被引数:7,505

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Global and regional reference curves for pain across the lifespan in 6.1 million individuals in 118 countries

全球和区域性疼痛参考曲线:基于118个国家610万名个体全生命周期的数据

2026-10-050
OAAI
Characterizing spatiotemporal white matter hyperintensity pathophysiology in vivo to disentangle vascular and neurodegenerative contributions

在体表征空间时间性白质高信号病理生理学,以区分血管性和神经退行性贡献

2026-03-310
OAAI
Longitudinal association between sleep and Alzheimer's pathology

睡眠与阿尔茨海默病病理的纵向关联

2026-03-100
OA
Associations of lifestyle factors with amyloid pathology in persons without dementia

生活方式因素与无痴呆人群淀粉样蛋白病理的相关性

2025-11-130
OA
The PREVENT-AD cohort: Accelerating Alzheimer's disease research and treatment in Canada and beyond

PREVENT-AD队列:加速加拿大及全球阿尔茨海默病的研究与治疗

2025-09-291
OAAI
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex

tau PET阳性率在伴有和不伴有认知障碍的个体中,随年龄、Aβ状态、APOE基因型和性别而变化。

2025-07-160
OA
Sex and APOE4-specific links between cardiometabolic risk factors and white matter alterations in individuals with a family history of Alzheimer's disease

性与APOE4特异性:阿尔茨海默病家族史个体中 cardiometabolic 风险因素与白质改变之间的关联

2025-06-010
OAAI
Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer's disease

一项针对有阿尔茨海默病风险的老年人增强身体活动的跨代际随机对照试验方案

2025-03-011
OAAI
Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year window

血浆p-tau217可识别在10年窗口期内将发展为认知障碍的认知正常的老年人

2025-02-261
OAAI
Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer's disease continuum

阿尔茨海默氏病连续体中两个神经解剖学AI维度的遗传和临床相关性

2024-10-051
OAAI